Here is proof that Colostrum beats flu shots!! Please have effective answers like this for your patients who are badly frightened about the new flu epidemic!
The simple straight forward facts are Colostrum beat the flu vaccine, and in some groups is 3 times more effective than vaccines. Also remember that Guillian-Barre Syndrome occurs following flu shots with amazing frequency; read the book The Autoimmune Epidemic by Donna Jackson Nakazawa.
The IMMUNI-T products from Longevity Plus have the best of everything including transfer factor from immunized cattle against infectious rhinotracheitis, which even provides increased immunity in humans to things like CMV. For those wanting primarily Colostrum then the choice is to use Beyond Immuni-T, whereas Immuni-T 2 adds many factors to the colostrum to help overcome acute infections and Immuni-T 3 is more for chronic long-term immune support, as in cancer patients.
Please be prepared to offer meaningful information about the alternatives you can count on and keep ACS 200 in stock and have plenty of Vitamin D, and lots of BIOE’NR-G’Y C, as no one knows for sure what this new flu epidemic is going to develop into.
Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Vaccine or Colostrum? You make the choice….
Clin Appl Thromb Hemost. 2007 Apr;13(2):130-6.
Prevention of influenza episodes with colostrum compared with vaccination in healthy and high-risk cardiovascular subjects: the epidemiologic study in San Valentino.
Cesarone MR, Belcaro G, Di Renzo A, Dugall M, Cacchio M, Ruffini I, Pellegrini L, Del Boccio G, Fano F, Ledda A, Bottari A, Ricci A, Stuard S, Vinciguerra G.
San Valentino-Spoltore Vascular Screening Project, Department of Biomedical Sciences, G D’annunzio University, Chieti, Pescara, Italy.
The efficacy of a 2-month treatment with oral colostrum in the prevention of flu episodes compared with antiinfluenza vaccination was evaluated. Groups included healthy subjects without prophylaxis and those receiving both vaccination and colostrum. After 3 months of follow-up, the number of days with flu was 3 times higher in the non-colostrum subjects. The colostrum group had 13 episodes versus 14 in the colostrum + vaccination group, 41 in the group without prophylaxis, and 57 in nontreated subjects. Part 2 of the study had a similar protocol with 65 very high-risk cardiovascular subjects, all of whom had prophylaxis. The incidence of complications and hospital admission was higher in the group that received only a vaccination compared with the colostrum groups. Colostrum, both in healthy subjects and high-risk cardiovascular patients, is at least 3 times more effective than vaccination to prevent flu and is very cost-effective.
